Poor positive predictive value of influenza-like illness criteria in adult transplant patients: A case for multiplex respiratory virus PCR testing

Clinical Transplantation

Volumn 29, Issue 10, 2015, Pages 938-943

  Claus, Jonathan A ^a   Hodowanec, Aimee C ^b   Singh, Kamaljit ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ILI criteria; Influenza; Influenza like illness; Respiratory virus; Transplantation

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; VIRUS DNA;

ADULT; AGED; ARTICLE; COMORBIDITY; CORONAVIRIDAE; ENTEROVIRUS; FEMALE; FLU LIKE SYNDROME; GRAFT RECIPIENT; HUMAN; INFLUENZA; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINATION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NONHUMAN; ORGAN TRANSPLANTATION; PARAMYXOVIRINAE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RESPIRATORY VIRUS; RHINOVIRUS; STEM CELL TRANSPLANTATION; VIRUS DETECTION; DECISION SUPPORT SYSTEM; DIFFERENTIAL DIAGNOSIS; GENETICS; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; ORTHOMYXOVIRIDAE; POSTOPERATIVE COMPLICATIONS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; DECISION SUPPORT TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; DNA, VIRAL; FEMALE; HUMANS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; ORGAN TRANSPLANTATION; ORTHOMYXOVIRIDAE; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION;

EID: 84942899120     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12600     Document Type: Article

References (19)

1. Kim Y, Boeckh M, Englund J. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med 2007: 28: 222.
2. Manuel O, Estabrook M. RNA respiratory viruses in solid organ transplantation. Am J Transplant 2013: 13: 212.
3. Vigil JV, Adachi JA, Chemaly RF. Analytic review: viral pneumonias in immunocompromised adult hosts. J Intensive Care Med 2010: 25: 307.
4. Lopez-Medrano F, Aguado JM, Lizasoain M et al. Clinical implications of respiratory virus infections in solid organ transplant recipients: a prospective study. Transplantation 2007: 84: 851.
5. Nicholson KG, Aoki FY, Osterhaus AD et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomized controlled trial. Lancet 2000: 355: 1845.
6. McGeer A, Green KA, Plevneshi A et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007: 45: 1568.
7. Boivin G, Hardy I, Tellier G, Maziade J. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis 2000: 31: 1166.
8. Cheng PK, Wong KK, Mak GC et al. Performance of laboratory diagnostics for the detection of influenza A (H1N1) virus as correlated with the time after symptom onset and viral load. J Clin Virol 2010: 47: 182.
9. Barenfanger J, Drake C, Leon N, Mueller T, Troutt T. Clinical and financial benefits of rapid detection of respiratory viruses: an outcomes study. J Clin Microbiol 2000: 38: 2824.
10. Van Elden LJR, van Kraaij MGJ, Nijhuis M et al. Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia. Clin Infect Dis 2002: 34: 177.
11. Mahony JB, Blackhouse G, Babwah J et al. Cost analysis of multiplex PCR testing for diagnosing respiratory virus infections. J Clin Microbiol 2009: 47: 2812.
12. Gueller S, Duenzinger U, Wolf T et al. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis 2013: 15: 435.
13. Hawkinson D, Hinthorn D, Danziger-Isakov L. Novel antiviral agents for respiratory viral infection in immunocompromised adults. Curr Infect Dis Rep 2013: 15: 497.
14. Campbell AP, Guthrie KA, Englund JA et al. Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant. Clin Infect Dis 2015: 61: 192.
15. Belongia EA, Kieke BA, Donahue JG et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009: 199: 159.
16. Kumar D, Blumberg EA, Danziger-Isakov L et al. Influenza vaccination in the solid organ transplant recipient: review and summary recommendations. Am J Transplant 2011: 11: 2020.
17. Engelhard D, Nagler A, Hardan I et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T-cell depleted and autologous BMT recipients. Bone Marrow Transplant 1993: 11: 1.
18. Danziger-Isakov L, Kumar D, the AST Infectious Diseases Community of Practice. Vaccination in solid organ transplantation. Am J Transplant 2013: 13: 311.
19. Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP) - United States, 2013-2014. MMWR Recomm Rep 2013: 62(RR-07): 1.